Search or choose
Find the right test or package.
PML - RARA Fusion
The PML-RARA fusion is a genetic alteration resulting from the fusion of the PML (promyelocytic leukemia) and RARA (retinoic acid receptor alpha) genes. It is a defining feature of acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia (AML)....
DiagnosticsLab test
Know more about this test
The PML-RARA fusion is a genetic alteration resulting from the fusion of the PML (promyelocytic leukemia) and RARA (retinoic acid receptor alpha) genes. It is a defining feature of acute promyelocytic leukemia (APL), a subtype of acute myeloid leukem...
Understanding PML - RARA Fusion
The PML-RARA fusion is a genetic alteration resulting from the fusion of the PML (promyelocytic leukemia) and RARA (retinoic acid receptor alpha) genes. It is a defining feature of acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia (AML). This fusion gene plays a critical role in the development of APL and is a target for specific therapies, such as all-trans retinoic acid (ATRA) and arsenic trioxide, which have significantly improved the prognosis for APL patients.
What does PML - RARA Fusion measure?
The PML-RARA fusion is a genetic alteration resulting from the fusion of the PML (promyelocytic leukemia) and RARA (retinoic acid receptor alpha) genes. It is a defining feature of acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia (AML). This fusion gene plays a critical role in the development of APL and is a target for specific therapies, such as all-trans retinoic acid (ATRA) and arsenic trioxide, which have significantly improved the prognosis for APL patients.
Related parameters
How does home sample collection work?
Select slot
Pick a convenient time.
Phlebotomist visit
A trained expert arrives home.
Safe testing
Samples move through the lab process.
Digital reports
Reports are delivered online.